Early Confirmed Speakers

 

 

John Alter, Vice President Pricing and Market Access, Pfizer

John Alter at Pharma Pricing & Market Access Congress 2019

Mauricio Alvarez Reyes, Market Access Director, Tesaro

Mauricio Alvarez Reyes at Pharma Pricing & Market Access Congress 2019

Katerina Anokhina, Director, Medical Affairs, UK & Ireland, Alexion Pharma UK

Katerina Anokhina at Pharma Pricing & Market Access Congress 2019

Diego Ardigo, R&D Rare Diseases Unit Head, Chiesi Farmaceutici SpA

Diego Ardigo at Pharma Pricing & Market Access Congress 2019

Francis Arickx, Head of the Directorate Reimbursement of Medicines and Pharmaceutical Policy,, National Institute for Health and Disability Insurance RIZIV-INAMI

Nadeem Ashraf, Medical Advisor - Diabetes, N/A

Nadeem Ashraf at Pharma Pricing & Market Access Congress 2019

Philip Aubrey, Associate Director Market Access Biosimilars, UK, Netherlands and Ireland, Biogen

Philip Aubrey at Pharma Pricing & Market Access Congress 2019

Katja Berg, Vice President of Operations and Payers Intelligence, Sanofi

Katja Berg at Pharma Pricing & Market Access Congress 2019

Axel Boehnke, Director Market Access (global responsibility), MorphoSys AG

Axel Boehnke at Pharma Pricing & Market Access Congress 2019

Luc Boileau, Président-directeur general, Inesss

Luc Boileau at Pharma Pricing & Market Access Congress 2019

David Boothe, Regional Commercial Head, Spark Therapeutics

David Boothe at Pharma Pricing & Market Access Congress 2019

Hassan Bruneo, Associate Director, Alnylam Switzerland Gmbh

Hassan Bruneo at Pharma Pricing & Market Access Congress 2019

Anna Bucsics, Project Advisor, Mechanism of Coordinated Access to orphan medicinal products (MoCA)

Anna Bucsics at Pharma Pricing & Market Access Congress 2019

Hector Castro, Senior Technical Director- Pharmaceutical Economics & Financing, Management Science For Health

Deven Chauhan, Senior Director, Value Evidence Leader, GlaxoSmithKline

Deven Chauhan at Pharma Pricing & Market Access Congress 2019

José Luis Sánchez Chorro, Head of Market Access, Shire Pharmaceuticals

José Luis Sánchez Chorro at Pharma Pricing & Market Access Congress 2019

Mike Crosher, Value & Access Director, Chugai Pharma UK

Mike Crosher at Pharma Pricing & Market Access Congress 2019

Omar Dabbous, Vice President Health Economics and Outcomes Research, AveXis Inc

Omar Dabbous at Pharma Pricing & Market Access Congress 2019

Charles De Cidrac, Director of Health Insurance, AXA

Charles De Cidrac at Pharma Pricing & Market Access Congress 2019

Carla Deakin, Associate Director, Office for Market Access, NICE

Carla Deakin at Pharma Pricing & Market Access Congress 2019

Will Dunlop, Head of Market Access, Mundipharma International Limited

Will Dunlop at Pharma Pricing & Market Access Congress 2019

Jenny Ebert, Account Director, Genzyme Sanofi Corp

Jenny Ebert at Pharma Pricing & Market Access Congress 2019

David Elvira Martinez, Director of the Catalan Health Service, CatSalut, Catalunya Health Service

David Elvira Martinez at Pharma Pricing & Market Access Congress 2019

Diar Fattah, Associate Director of Medicines Optimisation, N.H.S._Dartford Gravesham and Swanley C.C.G.

Diar Fattah at Pharma Pricing & Market Access Congress 2019

Matteo Ferrario, Value Strategy Manager, Roche

Matteo Ferrario at Pharma Pricing & Market Access Congress 2019

Martina Flammer, Senior Vice President, Head of Customer Value, Boehringer Ingelheim Pharma GmbH & Co. KG

Steven Flostrand, Senior Director of Pricing and Market Access, Celgene

Steven Flostrand at Pharma Pricing & Market Access Congress 2019

Oliver Gassner, Head Digital Health Intelligence | EMEA, Bayer

Oliver Gassner at Pharma Pricing & Market Access Congress 2019

Josie Godfrey, Director, JG Zebra Consulting

Josie Godfrey at Pharma Pricing & Market Access Congress 2019

Adrian Griffin, VP, HTA and Reimbursement Policy, Johnson & Johnson

Adrian Griffin at Pharma Pricing & Market Access Congress 2019

Mohamed Hamada, Country Portfolio Lead, Women’s Health – Egypt & Sudan, Pfizer

Mohamed Hamada at Pharma Pricing & Market Access Congress 2019

Tony Hebden, Vice President of Health Economics and Outcomes Research, AbbVie

Tony Hebden at Pharma Pricing & Market Access Congress 2019

Chris Hill, Head of Strategic Pricing UK & Ireland, Sanofi

Chris Hill at Pharma Pricing & Market Access Congress 2019

Alan Hochberg, Process Development Leader and DSC Office, F. Hoffmann-La Roche Ltd

Alan Hochberg at Pharma Pricing & Market Access Congress 2019

Karen Hockey, Director, Global Market Access & Government Affairs, Norgine Ltd

Karen Hockey at Pharma Pricing & Market Access Congress 2019

Lucy Hoppe, Clinical Effectiveness Manager (Evidence Synthesis) in the Clinical Effectiveness Team, Bupa

Lucy Hoppe at Pharma Pricing & Market Access Congress 2019

Jenny Hughes, Head, Market Access Capabilities, GSK

Jenny Hughes at Pharma Pricing & Market Access Congress 2019

Wills Hughes-Wilson, Head of Patient Access & Commercial Planning, Mereo BioPharma

Dawn Ireland, President, CDH International

Dawn Ireland at Pharma Pricing & Market Access Congress 2019

Daniel Jackson, Global Head of Market Access, Solutions and Strategy, UCB

Daniel Jackson at Pharma Pricing & Market Access Congress 2019

Navin Joshi, Head of Pricing & Access Capabilities EMAP, GlaxoSmithKline

Navin Joshi at Pharma Pricing & Market Access Congress 2019

Marcela Junqueira, Head of Value Demonstration and Access, Shire Farmacêutica Brasil Ltda

Marcela Junqueira at Pharma Pricing & Market Access Congress 2019

Sachin Kamal-Bahl, Vice President & Head, Global Health & Value Innovation Center, Pfizer

Sachin Kamal-Bahl at Pharma Pricing & Market Access Congress 2019

Nicki Kang, Head of Pricing UK and Ireland, Merck Group

Nicki Kang at Pharma Pricing & Market Access Congress 2019

Alison Kneen, Practice Lead, DRG Abacus

Jolanda Koenders, Head of Pricing and Market Access Pharma, Novartis

Jolanda Koenders at Pharma Pricing & Market Access Congress 2019

Brett Kopelan, Executive Director, DebRa of America

Brett Kopelan at Pharma Pricing & Market Access Congress 2019

Michael Lees, Head of Value, Evidence & Portfolio Strategy, Takeda

Michael Lees at Pharma Pricing & Market Access Congress 2019

Friedhelm Leverkus, Director Health Technology Assessment and Outcomes Research, Pfizer

Friedhelm Leverkus at Pharma Pricing & Market Access Congress 2019

Gordon Lundie, Director of Market Access, Gilead Sciences

Gordon Lundie at Pharma Pricing & Market Access Congress 2019

Mark Macgregor, Associate Medical Director and Clinical Advisor, Scottish Medicines Consortium, NHS National Services Scotland

Mark Macgregor at Pharma Pricing & Market Access Congress 2019

Steinar Madsen, Medical Director, Norwegian Medicines Agency, Norway

Steinar Madsen at Pharma Pricing & Market Access Congress 2019

Joerg Mahlich, Head HEOR, Janssen Pharmaceutical K.K.

Joerg Mahlich at Pharma Pricing & Market Access Congress 2019

Farzana Malik, Vice President Market Access, Vicarius Pharma

Farzana Malik at Pharma Pricing & Market Access Congress 2019

Andrea Mantovani, Director of Country Market Access, Amgen Inc

Andrea Mantovani at Pharma Pricing & Market Access Congress 2019

Anne Marciniak, Affiliate, BRUNEL UNIVERSITY

Anne Marciniak at Pharma Pricing & Market Access Congress 2019

Cristina Martin-Rinconada, Associate Director Strategic Pricing, Biogen Biosimilars Europe

Cristina Martin-Rinconada at Pharma Pricing & Market Access Congress 2019

Kevin Mayo, Head, Global Market Access - New Products, Shire Pharmaceuticals

Aurelio Mejia, Former Deputy Director of HTA, IETS

Aurelio Mejia at Pharma Pricing & Market Access Congress 2019

Soniya Mokashi, Global Senior Medical Affairs Physician, Norgine

Soniya Mokashi at Pharma Pricing & Market Access Congress 2019

Patrick Mollon, Former Director GHEORE, Shire

Tal Morginstin, Director, NLHS (National List of Health Services) Assessment Division, Ministry of Health

Tal Morginstin at Pharma Pricing & Market Access Congress 2019

Thomas Mueller, Head of Directorate General 1 "Drugs, Medical Devices, Biotechnology", Bundesministerium fur Gesundheit

Thomas Mueller at Pharma Pricing & Market Access Congress 2019

Diane Munch, Head of Global Pricing, Patient & Health Impact, Pfizer

Diane Munch at Pharma Pricing & Market Access Congress 2019

Jeff Myers, CEO, Medicaid Health Plans of America

Jeff Myers at Pharma Pricing & Market Access Congress 2019

Sue Naeyaert, Global Head Government Affairs and Policy Biosimilars, Fresenius Kabi

Sue Naeyaert at Pharma Pricing & Market Access Congress 2019

Alexander Natz, Secretary General, EUCOPE

Alexander Natz at Pharma Pricing & Market Access Congress 2019

Enkeleida Nikai, Director of RWE - Medical Affairs, Eli Lilly

Enkeleida Nikai at Pharma Pricing & Market Access Congress 2019

Melvin Olson, Global Head RWD Strategy and Innovation, Novartis Pharma

Melvin Olson at Pharma Pricing & Market Access Congress 2019

Vitaly Omelyanovskiy, General director, Center of Healthcare Quality Assessment and Control, Ministry of Health

Nneka Onwudiwe, PRO/PE Scientific Reviewer, Food and Drug Administration

Nneka Onwudiwe at Pharma Pricing & Market Access Congress 2019

Robert Orzechowski, Chief Operating Officer, Lancaster Cancer Centre

Robert Orzechowski at Pharma Pricing & Market Access Congress 2019

Elizabeth Owen, Head of Translational Research Development, The Muscular Dystrophy U.K.

Elizabeth Owen at Pharma Pricing & Market Access Congress 2019

Melissa Paige, UVA Cancer Center, Oncology Patient Access Principal Coordinator, Patient Advocate, U.V.A. Health System

Melissa Paige at Pharma Pricing & Market Access Congress 2019

Elena Panitti, Global RWE Capability Building Lead, Novartis

Elena Panitti at Pharma Pricing & Market Access Congress 2019

Detlev Parow, Head of Department of Medicines, Therapeutic Appliances and Remedies, D.A.K.

Detlev Parow at Pharma Pricing & Market Access Congress 2019

Marco Penske, Head of Market Access and Health Care Affairs, Boehringer Ingelheim Biopharmaceuticals Gmbh

Marco Penske at Pharma Pricing & Market Access Congress 2019

Dan Pettitt, Global Head of Immunology Market Access, Johnson & Johnson

Dan Pettitt at Pharma Pricing & Market Access Congress 2019

Ed Pezalla, Former Vice President, National Medical Director for Pharmaceutical Policy and Strategy, Aetna

Ed Pezalla at Pharma Pricing & Market Access Congress 2019

Tanya Potashnik, Director Policy & Economic Analysis, Patented Medicine Prices Review Board, Goverment Of Canada

Tanya Potashnik at Pharma Pricing & Market Access Congress 2019

Diann Potestio, Senior Director, National Accounts, Multiple Sclerosis & Immunology, Genzyme

Diann Potestio at Pharma Pricing & Market Access Congress 2019

Marco Rauland, Global Head Pricing & Payer Excellence, Merck Group

S D Ravetkar, Executive Director, Serum Institute of India Ltd

S D Ravetkar at Pharma Pricing & Market Access Congress 2019

Ajan Reginald, CEO, Celixir

Andrew Richards, Head of Global Market Access & Pricing, Ferring

Andrew Richards at Pharma Pricing & Market Access Congress 2019

Igor Rudychev, Sr. Director, Business Insights, Immuno-Oncology, AstraZeneca

Igor Rudychev at Pharma Pricing & Market Access Congress 2019

Peter Rutherford, Global Medical Lead of Orphan Renal Diseases, Vifor Pharma Group

Peter Rutherford at Pharma Pricing & Market Access Congress 2019

Stefan Scherer, VP Head of Early Development Strategy, McKesson Specialty Health The U.S. Oncology Network

Stefan Scherer at Pharma Pricing & Market Access Congress 2019

Gundula Schneidewind, Managing Director, Takeda Belgium

Gundula Schneidewind at Pharma Pricing & Market Access Congress 2019

Michael Schroter, Head of Personalised Reimbursment Models, Global Pricing and Market Access, Roche

Michael Schroter at Pharma Pricing & Market Access Congress 2019

Rob Scott, Chief Medical Officer, VP, Head of Development, AbbVie

Rob Scott at Pharma Pricing & Market Access Congress 2019

Simon Shohet, Senior Director, Global Market Access and Pricing, Ipsen

Simon Shohet at Pharma Pricing & Market Access Congress 2019

Tamir Singer, Head of Commercial Development, Specialised Commissioning, NHS England

Gerard Slevin, National hospitals manager, Clonmel Healthcare Ltd

Gerard Slevin at Pharma Pricing & Market Access Congress 2019

Erik Smets, Vice President and Head of Patient Experience and Value, UCB Biopharma

Erik Smets at Pharma Pricing & Market Access Congress 2019

Anastasiya Stepanova, State Authorities Manager, JSC Nizhpharm

Anastasiya Stepanova at Pharma Pricing & Market Access Congress 2019

Richard Stephens, Chair of Consumer Liaison Group, National Cancer Research Institute (NCRI)

Richard Stephens at Pharma Pricing & Market Access Congress 2019

Lotte Steuten, Associate Faculty Member, Fred Hutchinson Cancer Research Center

Renske Ten Ham, PhD Candidate, Utrecht University

Renske Ten Ham at Pharma Pricing & Market Access Congress 2019

Daria Tolkacheva, Head of Health Economics, JSC BIOCAD

Daria Tolkacheva at Pharma Pricing & Market Access Congress 2019

Jorg Tomeczkowski, Head of Market Access, Janssen Cilag Germany

Jorg Tomeczkowski at Pharma Pricing & Market Access Congress 2019

Keiko Tone, VP Market Access, Shionogi Limited

Keiko Tone at Pharma Pricing & Market Access Congress 2019

Ariella Toren, Director of Medicine and Medical Technologies, HMOs department, Israel - Ministry Of Health

Ariella Toren at Pharma Pricing & Market Access Congress 2019

Isabel Torres, Vice President Market Access, Public Affairs and Patient Advocacy for Europe and Canada, Takeda

Isabel Torres at Pharma Pricing & Market Access Congress 2019

Florian Turk, Head of Global Payor Marketing, Sales and Relations, Sandoz

Florian Turk at Pharma Pricing & Market Access Congress 2019

Sheela Upadhyaya, Associate Director Highly Specialised Technologies, National Institute for Health and Care Excellence

Sheela Upadhyaya at Pharma Pricing & Market Access Congress 2019

Maarten Van Baelen, Market Access Director, Medicines for Europe

Maarten Van Baelen at Pharma Pricing & Market Access Congress 2019

Goedele van Haasteren, HTA Specialist, Bundesamt fur Gesundheit

Bart Vermeulen, Deputy Director Healthcare at Office of the Minister of Social Affairs and Public Health, Belgian Federal Government

Bart Vermeulen at Pharma Pricing & Market Access Congress 2019

Reg Waldeck, Market Access Strategy Leader, Bayer Corp

Reg Waldeck at Pharma Pricing & Market Access Congress 2019

Darren Walsh, Senior Director - Market Access & Govt. Affairs – EU, Orchard Therapeutics

Darren Walsh at Pharma Pricing & Market Access Congress 2019

David Watson, Director Pricing and Reimbursement, Association of the British Pharmaceutical Industry

David Watson at Pharma Pricing & Market Access Congress 2019

Fabrizio Zucca, Director Patient Access DACH, Sobi

Fabrizio Zucca at Pharma Pricing & Market Access Congress 2019

 

DOWNLOAD PROSPECTUS